SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-24-000069
Filing Date
2024-02-13
Accepted
2024-02-12 18:30:09
Documents
73
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q bivi-20231231_10q.htm   iXBRL 10-Q 774233
2 EXHIBIT 31.1 bivi-20231231_10qex31z1.htm EX-31.1 12097
3 EXHIBIT 31.2 bivi-20231231_10qex31z2.htm EX-31.2 12262
4 EXHIBIT 32.1 bivi-20231231_10qex32z1.htm EX-32.1 5287
5 EXHIBIT 32.2 bivi-20231231_10qex32z2.htm EX-32.2 5138
  Complete submission text file 0001520138-24-000069.txt   4548117

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bivi-20231231.xsd EX-101.SCH 45718
7 XBRL CALCULATION FILE bivi-20231231_cal.xml EX-101.CAL 49299
8 XBRL DEFINITION FILE bivi-20231231_def.xml EX-101.DEF 129607
9 XBRL LABEL FILE bivi-20231231_lab.xml EX-101.LAB 300188
10 XBRL PRESENTATION FILE bivi-20231231_pre.xml EX-101.PRE 247421
74 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20231231_10q_htm.xml XML 660174
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39015 | Film No.: 24621872
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)